Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3-PRIMULTI trial.
In patients aged ≥75 years, clear evidence of a long-term (10 years) benefit of complete revascularization was not demonstrated, and the finding should be interpreted as inconclusive.